BPC-157 / TB-500 20mg Batch WOLV20-2607-01 COA

Independent laboratory batch record

This searchable page transcribes the identifying fields and reported results from Kovera Labs certificate KVR-2026-823BBF. Match the batch printed on the physical vial to WOLV20-2607-01, then use the unique Kovera verification link below.

Transition Biotech product
BPC-157 / TB-500 20mg
Laboratory-tested identity
BPC-157/TB-500
SKU
BB20
Batch
WOLV20-2607-01
Labeled quantity
20 mg
Report
KVR-2026-823BBF
Certified
2026-07-22
Issuing laboratory
Kovera Labs
Verification access code
YWDOZWU

Open the independent Kovera record

Complete batch-matched laboratory documents

These four original Kovera Labs PDFs apply to the same identified sample and batch. Match the vial batch before relying on any report.

Certificate of AnalysisKVR-2026-823BBF | PDFRapid Sterility ScreenRSTER-KVR-2026-823BBF | PDFHeavy-Metals AnalysisHM-KVR-2026-823BBF | PDFBacterial Endotoxin AnalysisENDO-KVR-2026-823BBF | PDF

Reported analytical results

TestReported result
Blend Average Purity99.571%
Blend Average Net Content20.24 mg
Blend Identification (LC-MS)BPC-157/TB-500
BPC-157 Component9.78 mg
TB-500 (TB-4) Component10.46 mg
Endotoxin Safety ScreenPass
Microbial Sterility ScreenNo Growth
pH5.7

Heavy-metal screening reported

AnalyteReported result
Arsenic (As)Negative
Cadmium (Cd)Negative
Lead (Pb)Negative
Mercury (Hg)Negative

Chromatography method reported: RP-HPLC; C18 column; DAD at 214 nm.

How to verify this vial

  1. Locate the QR code and batch number on the physical vial.
  2. Scan the QR code or open the independent Kovera record above.
  3. Confirm that the vial batch is exactly WOLV20-2607-01 and the report is KVR-2026-823BBF.
  4. Review the original laboratory record before relying on this transcription.

View BPC-157 / TB-500 20mg | How vial-to-COA traceability works | Search all batch records

Documentation limits

This record reports only the tests and results stated by Kovera Labs for the identified sample. It does not establish results for an unmatched batch, clinical safety, efficacy, or suitability for human or veterinary use. The original third-party record controls if any transcription differs.